drugset / Trial / NCT01744964

Apomorphine Effects on Experimental Pain

NCT01744964

Phase 0 Completed 105 enrolled Rambam Health Care Campus
RandomizedCrossoverTriple-blindBasic science

Summary

The aims of this study were to assess the effects of the dopamine agonist apomorphine on experimental pain models in healthy subjects and to explore the possible association between these effects and a common polymorphism within the dopamine transporter gene.

Timeline

Start
2009-07
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Apomorphine Unknown 1.5 mg

Indications

No indication recorded.